Exercise of Warrants & Issue of Ordinary Shares and Total Voting Rights
September 21, 2020 06:00 ET
|
Amryt Pharma plc
AMRYT PHARMA PLC (“Amryt” or the “Company”) Exercise of Warrants & Issue of Ordinary Shares and Total Voting Rights DUBLIN, Ireland, and Boston MA, September 21 2020, Amryt (Nasdaq: AMYT, AIM:...
AMRYT RECEIVES POSITIVE OPINION FROM EMA ON ORPHAN DRUG DESIGNATION FOR AP103
September 15, 2020 07:00 ET
|
Amryt Pharma Plc
AMRYT PHARMA PLC (“Amryt” or the “Company”) AMRYT RECEIVES POSITIVE OPINION FROM EMA ON ORPHAN DRUG DESIGNATION FOR AP103 DUBLIN, Ireland, and Boston MA, September 15 2020, Amryt (Nasdaq: AMYT,...
POSITIVE TOP LINE RESULTS FROM PHASE 3 TRIAL IN EB
September 09, 2020 07:01 ET
|
Amryt Pharma Plc
AMRYT PHARMA PLC (“Amryt” or the “Company”) AMRYT ANNOUNCES POSITIVE TOP LINE RESULTS FROM PIVOTAL PHASE 3 “EASE” TRIAL OF FILSUVEZ® IN EPIDERMOLYSIS BULLOSA - Primary endpoint met with...
AMRYT PHARMA NOTIFICATION OF CANCELLATION OF ADMISSION TO EURONEXT GROWTH
August 11, 2020 06:09 ET
|
Amryt Pharma Plc
AMRYT PHARMA PLC (“Amryt” or the “Company”) NOTIFICATION OF CANCELLATION OF ADMISSION TO EURONEXT GROWTH DUBLIN, Ireland, and Boston MA, August 11, 2020, Amryt, (Nasdaq: AMYT, AIM: AMYT, Euronext...
AMRYT ANNOUNCES Q2 2020 RESULTS AND ISSUES POSITIVE REVENUE GUIDANCE FOR FY 2020
August 06, 2020 07:01 ET
|
Amryt Pharma Plc
AMRYT ANNOUNCES Q2 2020 RESULTS AND ISSUES POSITIVE REVENUE GUIDANCE FOR FY 2020 New revenue guidance of $170M - $175M in 2020 Conference call and webcast today 0830 ET / 1330 BST DUBLIN,...
AMRYT TO HOST KEY OPINION LEADER CALL ON EPIDERMOLYSIS BULLOSA DISEASE LANDSCAPE
July 29, 2020 07:00 ET
|
Amryt Pharma Plc
AMRYT PHARMA PLC (“Amryt” or the “Company”) AMRYT TO HOST KEY OPINION LEADER CALL ON EPIDERMOLYSIS BULLOSA DISEASE LANDSCAPE Monday, August 3, 2020 at 1000 ET / 1500 BST DUBLIN, Ireland, and...
AMRYT TO ANNOUNCE Q2 RESULTS ON AUGUST 6, 2020
July 20, 2020 07:00 ET
|
Amryt Pharma Plc
AMRYT PHARMA PLC (“Amryt” or the “Company”) AMRYT TO ANNOUNCE Q2 RESULTS ON AUGUST 6, 2020 DUBLIN, Ireland, and Boston MA, July 20 2020, Amryt (Nasdaq: AMYT, AIM: AMYT, Euronext Growth: AYP), a...
AMRYT LISTED ON NASDAQ AND CEO TO RING NASDAQ CLOSING BELL
July 08, 2020 10:04 ET
|
Amryt Pharma Plc
THIS ANNOUNCEMENT IS FOR INFORMATION PURPOSES ONLY AND IS NOT AN OFFER OF SECURITIES IN ANY JURISDICTION THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR IMMEDIATE RELEASE AMRYT PHARMA PLC ...
AMRYT PHARMA PLC: Posting of Annual Report and Notice of Agm
June 30, 2020 07:00 ET
|
Amryt Pharma Plc
THIS ANNOUNCEMENT IS FOR INFORMATION PURPOSES ONLY AND IS NOT AN OFFER OF SECURITIES IN ANY JURISDICTION AMRYT PHARMA PLC (“Amryt” or the “Company”) POSTING OF ANNUAL REPORT AND NOTICE OF AGM ...
Amryt publicly files registration statement for impending US listing on Nasdaq
June 23, 2020 17:40 ET
|
Amryt Pharma Plc
THIS ANNOUNCEMENT IS FOR INFORMATION PURPOSES ONLY AND IS NOT AN OFFER OF SECURITIES IN ANY JURISDICTION THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR IMMEDIATE RELEASE AMRYT PHARMA PLC...